Inicio › Glioma › Nueva York › New York City
Ensayos clínicos de Glioma en New York City, NY
25 estudios para Glioma buscan participantes en centros de New York City y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
ReclutandoFase 1/2
- Research Site, New York
- Research Site, New York
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
ReclutandoFase 1/2
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
ReclutandoFase 2
- Columbia University Irving Medical Center, New York
A Study of Mirdametinib in People With Central Nervous System Tumors
ReclutandoFase 1/2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Glioma Developmental and HyperActive Ras Tumor (DHART) Board
ReclutandoEstudio observacional
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
ReclutandoFase 3
- NYU Langone Health, New York
- Icahn School of Medicine at Mount Sinai, New York
- Columbia University Medical Center, New York
- y 1 más
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
ReclutandoFase 1
- New York University, New York
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies
ReclutandoFase 4
- New York Presbyterian Hospital-Columbia University Medical Center, New York
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma
ReclutandoFase 1
- NYU Langone Health, New York
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
ReclutandoFase 2
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Pembrolizumab, Olaparib, and Temozolomide for People With Glioma
ReclutandoFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Glioblastoma
Reclutando
- NYU Langone Health, New York
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric Gliomas
ReclutandoFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
Chronic CED of TPT for Recurrent Malignant Glioma
ReclutandoFase 1
- Columbia University Irving Medical Center / NewYork-Presbyterian Hospital, New York
A Study of 177Lu-PSMA-617 in People With Gliomas
ReclutandoFase 1
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBM
ReclutandoFase 3
- Lenox Hill Brain Tumor Center, New York
Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
Reclutando
- Lenox Hill Brain Tumor Center, New York
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)
Reclutando
- Lenox Hill Brain Tumor Center, New York
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors
ReclutandoFase 1
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Columbia University Medical Center, New York
- Memorial Slone Kettering Cancer Center, New York
Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252
ReclutandoFase 1
- Memorial Sloan Kettering, New York
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
ReclutandoFase 1/2
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOA
ReclutandoFase 2
- Lenox Hill Brain Tumor Center, New York
FUS Etoposide for DMG
ReclutandoFase 1
- Columbia University Irving Medical Center, New York
Concurrent XRD-0394 With Radiation Therapy for High Grade Gliomas
ReclutandoFase 1 temprana
- NYU Langone Health, New York
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors
Reclutando
- Memorial Sloan Kettering Cancer Center, New York
Ensayos de Glioma en otras ciudades
- Houston, TX23 estudios
- Boston, MA20 estudios
- Washington, DC19 estudios
- Philadelphia, PA16 estudios
- Columbus, OH15 estudios
- Miami, FL15 estudios
- San Francisco, CA14 estudios
- Chicago, IL13 estudios
- Durham, NC12 estudios
- Seattle, WA11 estudios
- St. Louis, MO10 estudios
- Aurora, CO10 estudios
Otros estudios en New York City
- Cáncer de seno136 estudios
- Cáncer de pulmón de células no pequeñas121 estudios
- Cáncer (todos los tipos)109 estudios
- Cáncer de próstata103 estudios
- Cáncer metastásico93 estudios
- Cáncer del colon y del recto78 estudios
- Cáncer de ovario69 estudios
- Cáncer de pulmón60 estudios
- Mieloma múltiple60 estudios
- Cáncer de páncreas60 estudios
- Cáncer de endometrio52 estudios
- Leucemia mielógena aguda51 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.